HDAC Inhibitor (IMAGE)
Caption
Treatment of mesenchymal cancer cells with an HDAC inhibitor induces augmentation of the expression level of miR-200c, which then induces reverse-transition of the cancer cells to restore epithelial characteristics; such cancer cells with reverse-transition are now sensitive to molecular-targeted drugs.
Credit
Kanazawa University
Usage Restrictions
The image may only be used with appropriate caption and credit.
License
Licensed content